Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery.
about
Drug delivery systems and combination therapy by using vinca alkaloidsDoxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PETMulticentre, Prospective Observational Study of Pegfilgrastim Primary Prophylaxis in Patients at High Risk of Febrile Neutropenia in Poland: PROFIL Study1-Pamitoyl-2-Linoleoyl-3-Acetyl-rac-Glycerol May Reduce Incidence of Gemcitabine-Induced Neutropenia: A Pilot Case-Controlled Study.
P2860
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hodgkin lymphoma treatment wit ...... mpaired chemotherapy delivery.
@ast
Hodgkin lymphoma treatment wit ...... mpaired chemotherapy delivery.
@en
Hodgkin lymphoma treatment wit ...... mpaired chemotherapy delivery.
@nl
type
label
Hodgkin lymphoma treatment wit ...... mpaired chemotherapy delivery.
@ast
Hodgkin lymphoma treatment wit ...... mpaired chemotherapy delivery.
@en
Hodgkin lymphoma treatment wit ...... mpaired chemotherapy delivery.
@nl
prefLabel
Hodgkin lymphoma treatment wit ...... mpaired chemotherapy delivery.
@ast
Hodgkin lymphoma treatment wit ...... mpaired chemotherapy delivery.
@en
Hodgkin lymphoma treatment wit ...... mpaired chemotherapy delivery.
@nl
P2093
P2860
P356
P1476
Hodgkin lymphoma treatment wit ...... mpaired chemotherapy delivery.
@en
P2093
Eva Culakova
Gary H Lyman
Ruth Pettengell
Thomas D Szucs
P2860
P2888
P356
10.1186/1756-8722-3-27
P577
2010-08-19T00:00:00Z
P5875
P6179
1051405042